The Eficiency in The Management of Facial Fracture Patients in Developing Country by Using OsiriX®, A Free 3D-Rendering Software
Article Sidebar
Main Article Content
Abstract
Background: Being a developing country with a GNI (Gross National Income) per capita of US$3,830, the cost for managing patients with facial fractures was often unaffordable. The use of a free 3D-rendering software presumably would decrease cost. With OsiriX, a free and open source 3D-rendering software, complex images manipulations and real-time 3D image visualization is easily accessible anytime and anywhere from the surgeon’s personal computer, making diagnosis and preoperative planning more convenient for the surgeons.
Patients and methods: From December 2009 to January 2010, 14 patients with facial fracture were admitted to our unit. Seven of them underwent surgery. Preoperatively, diagnosis & surgery plan was developed using OsiriX.
Results: By using OsiriX, more accurate diagnosis was made at a lower cost. Patients could save up to 48.1% from total diagnostic cost (19.2% from monthly income). OsiriX provided easier access to multidimensional navigation and visualization tools in personal computers, making easier planning possible for surgical steps and materials needed.
Summary: OsiriX being free and open source is bene!cial from !nancial point of view, which is an important point for patients in a developing country. It is user friendly and ef!cient in developing treatment plan for facial fracture patients.
Article Details
Authors retain the copyright of the article and grant Jurnal Plastik Rekonstruksi the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License. Articles opting for open access will be immediately available and permanently free for everyone to read, download and share from the time of publication. All open access articles are published under the terms of the Creative Commons Attribution-Non-commercial-NoDerivatives (CC BY-NC-ND) which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission.
